Coronary disease & ACS

Immunomodulatory effect of different statin regimens on regulatory T-cells in patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials

Eur Heart J Cardiovasc PharmacotherPublished Systematic review and network meta-analysis of randomised trials

Authors' conclusion

The findings of our study indicated that both high- and low-dose statin groups increased Treg frequency compared with the control group. IST demonstrated greater benefits than CST. Furthermore, statin therapy increased IL-10 and TGF-β levels and decreased IFN-γ levels.

Study context

Population
Patients with ACS
Participants
505 patients5 randomized clinical trials (RCTs)
Comparison
Low-dose conventional statin therapy (CST) and high-dose intensive statin therapy (IST) vs control
Outcome
Frequency of Tregs (and associated cytokines IFN-γ, IL-10, TGF-β)
Methodological detailsrandom-effects model, Grading of Recommendations, Assessment, Development and Evaluations (GRADE), RCTs published until June 2021 (PubMed, Cochrane Library, EMBASE)
  • Random-effects model
  • GRADE
  • RCTs published until June 2021 (PubMed, Cochrane Library, EMBASE)

Pooled result

As reported in the abstract

Treg frequency
Each group vs controlSMD (95% CI)P value
CST
1.77(0.77–2.76)
P = 0.0005
IST
2.12(1.15–3.10)
P < 0.0001

Further pooled results

OutcomeSMD (95% CI)P value
IL-10 levelsCSTvs Control2.69 (2.07–3.31)P < 0.0001
IL-10 levelsISTvs Control2.14 (1.76–2.52)P < 0.0001
TGF-β levelsCSTvs Control3.83 (0.63–7.0)P = 0.0189
IFN-γ levelsISTvs Control−1.52 (−1.94-1.10)P < 0.0001
IFN-γ levelsCSTvs Control−2.34 (−2.73-1.95)P < 0.0001

TGF-β levels

Association not seen with IST

Original publication

Immunomodulatory effect of different statin regimens on regulatory T-cells in patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Pharmacother. Published 1 September 2022. doi:10.1093/ehjcvp/pvac047

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.